Current Edition

Volume 13 Issue 6

Integrated CDMO Growth Will Lead to Patients Seeing Record Number of Drugs Making it to Market

It’s undoubtedly a very interesting time for the global CRO industry. This is particularly true for CROs with locations across the world who have been able to leverag...
Continue Reading →
Regional News

Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more

With a self-proclaimed “Super Plant” already on the way in South Korea, Samsung Biologics CEO John Rim said in January that the CDMO’s expansion push was just getting...
Continue Reading →

Quotient Sciences Launches as the New Global Identity for Quotient Clinical

Quotient Clinical, the drug development services organization, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS ...
Continue Reading →